Rajkamal Synthetics Ltd

CFO appointment

• Appointment of Ms. Mumal Kanwar as CFO and KMP, effective 26 Sep 2026.
• Terms of appointment as approved by the Board.
• Profile: ICSI Associate Member; PG from University of Rajasthan; expertise in corporate, regulatory, secretarial, financial.
• Relationship: sister-in-law of MD & CEO Ankur Ajmera.

Rajkamal Synthetics Limited — Trading Window Closed from October 1, 2026 till 48 hours after the declaration of Unaudited Financial Results for the quarter ending September 30, 2026.

Key investor updates

• Revised consolidated audited quarterly and annual results for year ended March 31, 2026.
• Independent Auditor's Report issued with an unmodified opinion on the revised results.
• Acquisitions completed: Eliraluxe Skincare and RKR Mines become wholly-owned; Indo Frame becomes 51% owned.
• Correction adjusts Indo Frame consolidation from 100% to 51%, affecting non-controlling interest and equity.
• Auditor's conclusion remains unchanged despite consolidation adjustment.
• First-time consolidated financial results prepared for year ended March 31, 2026.
• Board approved the year-end consolidated results on May 29, 2026.
• Figures for comparability recasted due to consolidation changes.

Financial snapshot

• Standalone revenue from operations: ₹569.20 lakh; PAT: ₹25.70 lakh; PBT: ₹32.85 lakh; EPS: ₹0.39.
• Consolidated revenue from operations: ₹1,099.18 lakh; PAT: ₹27.61 lakh; EPS: ₹0.42.
• Dividend for FY2025-26: not declared.
• Equity capital: 66,02,000 shares; paid-up ₹660.20 lakh.
• Net worth: ₹852.20 lakh.
• Cash and cash equivalents: Standalone ₹128.26 lakh; Consolidated ₹203.56 lakh.
• Current borrowings: Standalone ₹22.25 lakh; Consolidated ₹22.66 lakh.

Group structure & investments

• Three subsidiaries: Eliraluxe Skincare (100%), RKR Mines (100%), Indoframe Industries (51%).
• Indoframe Industries is a 51% subsidiary.
• Investments in subsidiaries at 31-03-2026 total ₹150.57 lakh.
• Eliraluxe Skincare: 10,00,000 shares; RKR Mines: 20,00,000; Indoframe: 15,35,100.

Governance & leadership

• Arihant Jain resigned as Executive Director and CFO on 28 June 2026.
• Ankur Ajmera remains Managing Director & CEO.
• Board: 5 Directors; 3 Independent; 1 Woman; 2 Executive.

Audit & compliance

• Statutory auditors ADV & Associates reappointed for five years to 2029; no qualifications.
• Secretarial audit by K. P. Ghelani & Associates; Annexure MR-3; no qualifications.
• Corporate governance report exemption noted due to capital/net worth thresholds.

Outlook & risks

• Raw material price volatility risk profitability.
• Macro-economic slowdown and export demand uncertainty.
• Logistics challenges; company strengthening supply chain.

Margins & profitability

• Standalone PAT margin 4.87%; Standalone PBT margin 6.22%.
• Consolidated PAT margin 2.48%; Consolidated PBT margin 3.36%.
• Management aims to improve turnover via cost reductions and marketing.

CSR & governance exemptions

• CSR not applicable; no ongoing CSR projects.
• Corporate governance report not required given thresholds.

AGM & corporate actions

• 45th AGM on Sept 30, 2026 via VC/OAVM; notices on website and stock exchanges.
• Shares listed on BSE (Code 514028); ISIN INE376L01013; annual listing fee paid for 2026-27.

Key disclosure

• Annual Report 2025-2026 and AGM notice sent to unregistered email addresses per Regulation 36(1)(b) LODR.
• Letter enclosing web link to access Annual Report; enclosed copy for records.
• Annual Report accessible on company website and stock exchange portals.
• Regulatory reference: Regulation 36(1)(b) of SEBI LODR 2015.
• Filed date: September 8, 2026.
• Shareholders encouraged to register emails with their DP for future communications.

Board actions

• Board approved unaudited standalone and consolidated results for quarter ended 30 June 2026.

Financial performance

• Consolidated revenue from operations: Rs 105.63 lakh for Q1 2026.
• Standalone net loss: Rs 13.53 lakh; basic/diluted EPS: Rs -0.20.
• Consolidated EPS: Rs -0.13 (basic and diluted) for Q1 2026.

Operations & segment

• Company operates in a single business segment; segment reporting not applicable.

Meeting Details

• Board meeting scheduled on August 13, 2026; time and venue not disclosed.

Key Agenda Items

• Approve unaudited standalone and consolidated financial results with Limited Review for quarter ended June 30, 2026.
• Any other business forming part of the agenda paper.

Other Notes

• Trading window closed from July 01, 2026 until 48 hours after the June 30, 2026 results declaration.